Literature DB >> 32950412

Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy.

William J Richter1, Jan A Nguyen1, Andrew E Wu1, Mark T Jennings1, Noah Lechtzin1, Nicole M Parrish2, Kevin J Psoter3, Keira A Cohen4.   

Abstract

Entities:  

Keywords:  Azithromycin; Drug resistance; Macrolide; Mycobacterium avium complex (MAC); Nontuberculous mycobacteria

Mesh：

Substances：

Year:  2020        PMID： 32950412      PMCID： PMC8406041          DOI： 10.1016/j.jcf.2020.09.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  6 in total

1.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 2.  Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.

Authors:  Peter J Mogayzel; Edward T Naureckas; Karen A Robinson; Gary Mueller; Denis Hadjiliadis; Jeffrey B Hoag; Lisa Lubsch; Leslie Hazle; Kathy Sabadosa; Bruce Marshall
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

3.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Authors:  David E Griffith; Barbara A Brown-Elliott; Brett Langsjoen; Yansheng Zhang; Xi Pan; William Girard; Kenwyn Nelson; James Caccitolo; Julio Alvarez; Sara Shepherd; Rebecca Wilson; Edward A Graviss; Richard J Wallace
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

Review 4.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

5.  Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Authors:  Seong Mi Moon; Hye Yun Park; Su-Young Kim; Byung Woo Jhun; Hyun Lee; Kyeongman Jeon; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.

Authors:  Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2018-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.